![]() Imaging refers to medical imaging techniques, such as x-ray and computerized tomography.If you use supplemental oxygen, we still need medical evidence to establish the severity of your respiratory disorder.We may not need all of this evidence depending on your particular respiratory disorder and its effects on you. Pulmonary function tests (see 3.00D4), other relevant laboratory tests, and descriptions of any prescribed treatment and your response to it. Medical evidence should include your medical history, physical examination findings, the results of imaging (see 3.00D3), We need medical evidence to document and assess the severity of your respiratory disorder.What documentation do we need to evaluate your respiratory disorder? VI means volume of inhaled gas during a DLCO test.ĭ.SpO 2 means percentage of oxygen saturation of blood hemoglobin measured by pulse oximetry.PaCO 2 means arterial blood partial pressure of carbon dioxide.PaO 2 means arterial blood partial pressure of oxygen.mL CO (STPD)/min/mmHg means milliliters of carbon monoxide at standard temperature and pressure, dry, per minute, per millimeter of mercury.FEV 1 means forced expiratory volume in the first second of a forced expiratory maneuver.DLCO means diffusing capacity of the lungs for carbon monoxide.COPD means chronic obstructive pulmonary disease.CFTR means CF transmembrane conductance regulator.BTPS means body temperature and ambient pressure, saturated with water vapor.BiPAP means bi-level positive airway pressure ventilation.What abbreviations do we use in this body system? What are the symptoms and signs of respiratory disorders? Symptoms and signs of respiratory disorders include dyspnea (shortness of breath), chest pain, coughing, wheezing, sputum production, hemoptysis (coughing up blood from the respiratory tract), use of accessory muscles of respiration, and tachypnea (rapid rate of breathing).Ĭ. We evaluate the pulmonary effects of neuromuscular and autoimmune disorders under these listings or under the listings in 11.00 or 14.00, respectively.ī. ![]() We evaluate cancers affecting the respiratory system under the listings in 13.00. We also use listings in this body system to evaluate respiratory failure ( 3.04D or 3.14),Ĭhronic pulmonary hypertension ( 3.09), and lung transplantation ( 3.11). (chronic bronchitis and emphysema, 3.02), pulmonary fibrosis and pneumoconiosis ( 3.02),Ĭystic fibrosis ( 3.04), and bronchiectasis ( 3.02 or 3.07). Examples of such disorders and the listings we use to evaluate them include chronic obstructive pulmonary disease Or that interfere with diffusion (gas exchange) across cell membranes in the lungs. We evaluate respiratory disorders that result in obstruction (difficulty moving air out of the lungs) or restriction (difficulty moving air into the lungs), Which disorders do we evaluate in this body system? Category of Impairments, Respiratory DisordersĬhronic pulmonary hypertension due to any causeĪ. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |